Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
KETOTIFEN FUMARATE
Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.
R06AX17
KETOTIFEN FUMARATE
1 Milligram
Tablets
Product subject to prescription which may be renewed (B)
Other antihistamines for systemic use
Authorised
2014-02-14
1 PACKAGE LEAFLET: INFORMATION FOR THE USER ZADITEN® 1 MG TABLETS {Ketotifen as Ketotifen hydrogen fumarate} READ ALL OF THIS LEAFLET CAREFULLY BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. WHAT IS IN THIS LEAFLET: 1. What Zaditen is and what it is used for 2. What you need to know before you take Zaditen 3. How to take Zaditen 4. Possible side effects 5. How to store Zaditen 6. Contents of the pack and otherinformation 1. WHAT ZADITEN IS AND WHAT IT IS USED FOR The name of your medicine is Zaditen and it contains ketotifen. It belongs to a group of drugs which have anti-allergic activities and it is used to help prevent asthma attacks and treat allergic conditions such as rhinitis. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE ZADITEN DO NOT TAKE ZADITEN - if you are allergic to ketotifen or any of the other ingredientsof Zaditen (listed in section 6). - if you have epilepsy. - if you are taking any oral medicines for diabetes - if you are breastfeeding WARNINGS AND PRECAUTIONS - Zaditen is not effective in preventing or treating acute asthma attacks - Do not stop taking other asthma medications unless your doctor tells you to, however well you feel. - During the first few days of treatment your reactions may be impaired (i.e. you may feel drowsy or your reactions may be slower than usual, Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Zaditen 1 mg Tablets. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 1mg ketotifen (as the hydrogen fumarate). _Excipients_ Each tablet contains 96.88 mg of lactose as lactose monohydrate. (see section 4.4 special warnings and precautions for use). For a full list of excipients, see section 6.1 List of excipients. 3 PHARMACEUTICAL FORM Tablets White, or yellow-tinged white, circular, flat, bevel-edged tablets with breakline, weighing 130mg, 7mm diameter. The scoreline is only to facilitate breaking for ease of swallowing and not to divide into equal doses. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Preventative treatment of bronchial asthma especially when associated with atopic symptoms. Symptomatic treatment of allergic conditions including rhinitis and conjunctivitis. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Oral administration. ADULTS1 mg twice daily with food. In patients susceptible to sedation, a slow increase in dosage is recommended during the first week of treatment, starting with ½ tablet twice daily, and increasing to the full therapeutic dose. If necessary the dose may be increased to 2 mg twice daily. At the higher dose, an accelerated onset of efficacy may be expected. Special populations Pediatrics Children aged 2 to 3 years:For younger children, who cannot swallow tablets or where the required dose cannot be administered using tablets, Zaditen Oral Solution 1mg/5ml is available. Dosage: 0.05 mg (=0.25 ml Zaditen Oral solution 1mg/5ml) per kilogram body weight twice daily (morning and evening). Children over 3 years of age and adolescents:1mg twice daily with food. Geriatrics (aged 65 years and above) No evidence exists that elderly patients require different dosages or Read the complete document